Navigation Links
PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy
Date:1/19/2010

SOUTH PLAINFIELD, N.J., Jan. 19 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of an additional clinical trial of ataluren (PTC124®) in boys and young men with nonsense mutation Duchenne/Becker muscular dystrophy (nmDBMD) who have permanently lost the ability to walk independently.  This trial is evaluating the best methods for measuring functional abilities in patients who have lost independent mobility.  Patients with nmDBMD develop progressive muscle weakness that leads to deterioration of ambulation, wheelchair dependency, progressive loss of upper limb strength, and eventual respiratory and cardiac failure.  The study, which is expected to complete enrollment rapidly, is being funded in part by a $1 million grant from the Muscular Dystrophy Association, and will involve MDA's five-center DMD Clinical Research Network and a site in the United Kingdom.  

(Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )

"Given the relentlessly progressive course of DBMD and its impact on multiple organ systems, we believe patients could benefit from therapeutic interventions at all stages of the disease.  This trial is an important step in understanding the best methods for evaluating new clinical treatments for these boys and young men," stated Langdon Miller, M.D., Chief Medical Officer at PTC.  

"The Muscular Dystrophy Association is proud to provide $1 million in funding towards thi
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
2. Echo Therapeutics Announces Major Milestone: The Completion of Product Development Work of its Revolutionary, Patented Prelude(TM) SkinPrep System
3. Advanced Cardiac Therapeutics Completes $5 Million Financing
4. Cell Therapeutics, Inc. (CTI) to Present at the 28th Annual JP Morgan Healthcare Conference
5. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
6. Anesiva Announces Merger With Arcion Therapeutics Will Not be Completed
7. Cell Therapeutics, Inc. Adopts Shareholder Rights Plan
8. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
9. PTC Therapeutics Closes $50 Million Financing
10. Fate Therapeutics iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs
11. European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- AVACEN, Inc. announced today the issue by the US Patent ... platform supporting its unique Dry Heat Therapy AVACEN 100 product. ... http://photos.prnewswire.com/prnh/20150630/227364LOGO ... Methods And Apparatus For Therapeutic Application of Thermal Energy shields ... use, referred to by the company as the AVACEN ...
(Date:7/1/2015)... has acquired West Bend Assisted Living Pharmacy ( ... a proven track record for excellent service to individuals ... involved in their care. Both companies have strong reputations ... to their customers. Genoa ... dedicated to the behavioral health community and those affiliated ...
(Date:7/1/2015)... BALTIMORE , July 1, 2015   Continental Clinical Solutions (Continental) announced it ... from private practice to accommodate increased volume in clinical studies and demand for unique patient ... ... ... ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Genoa, a QoL Healthcare Company Acquires West Bend Assisted Living Pharmacy 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4
... NxStage Medical, Inc. (Nasdaq: NXTM ), a ... addition of Nancy J. Ham to the Company,s Board ... Mr. Silverstein, General Partner of OrbiMed, joined ... in which OrbiMed was the lead investor.  "Jonathan has ...
... Calif., Jan. 24, 2011 Biomerix Corporation announced today ... REVIVE™ soft tissue repair mesh allowing for the marketing ...    REVIVE received 510(k) clearance from the U.S. Food ... REVIVE is constructed of the Biomerix Biomaterial™, a proprietary, ...
Cached Medicine Technology:NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein 2Biomerix Granted CE Mark for its REVIVE™ Soft Tissue Repair Mesh 2
(Date:7/1/2015)... New York (PRWEB) , ... July 01, 2015 ... ... lawsuit filed against the manufacturers of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the ... District Court, Southern District of West Virginia on June 26th, the Court rejected ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... announced that they will welcome four new members to their industry leading Scientific ...
(Date:7/1/2015)... PA (PRWEB) , ... July 01, 2015 , ... ... purist natural forms, such as organically raised chickens and eggs. Eating organic foods ... backyard chickens is cleaner and more environmentally friendly than production chicken farming. Choosing ...
(Date:7/1/2015)... ... 2015 , ... The Collaborative for Children and Families (CCF) announced that it ... allow CCF to improve quality of care and save costs for the child welfare ... many changes in New York’s Medicaid system. Experts agree that children need thorough solutions ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Summer recess has ... teenagers to fix noses and chins with plastic surgery when they’re looking for a ... more than 236,000 cosmetic procedures were performed on patients ages 19 and younger in ...
Breaking Medicine News(10 mins):Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3
... , , WASHINGTON, Dec. 24 Speaker ... Senate voting 60 to 39 to pass historic health insurance ... States Senate brings us closer to providing quality, affordable health ... strong leadership in passing this bill, which takes a critical ...
... WASHINGTON , Dec. 24 ... passing historic health reform legislation. , "Thanks to today,s Senate vote, ... our nation,s health system," said Georges C. Benjamin, MD, FACP, FACEP ... will help reduce disability and death in the United States, lays ...
... could be dominant strain this winter, ,crowding out, typical seasonal ... The month of December typically marks the start of the ... H1N1 swine flu back in April, nothing has been typical ... And in the topsy-turvy world that is flu research right ...
... ... offering to deliver point-of-care drug information on Android devices, , ... Hudson, OH (PRWEB) December ... solutions for healthcare professionals, has released an application for Google Android devices. ...
... ... Inc., a leading manufacturer of linear motion products, introduces the G4 37000 Series Can-stack ... ... 24, 2009 -- Haydon Kerk Motion Solutions, Inc ., a leading manufacturer of ...
... ... For Holidays , ... (PRWeb UK) December 23, 2009 -- All professional drug and alcohol rehabilitation clinics across ... admissions, suicides and deaths increase significantly during the Christmas festive season above any other ...
Cached Medicine News:Health News:APHA Applauds Senate for Advancing Health Reform Bill 2Health News:Swine Flu May Be Rewriting the Flu-Season Script 2Health News:Swine Flu May Be Rewriting the Flu-Season Script 3Health News:Lexi-Comp Now Available for Android™ 2Health News:Haydon Kerk Motion Solutions Introduces the NEW G4 37000 Series Stepper Motor Linear Actuator 2Health News:Drug And Alcohol Rehab Clinics Professionals Prepare For The Christmas And New Year Holidays 2Health News:Drug And Alcohol Rehab Clinics Professionals Prepare For The Christmas And New Year Holidays 3
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: